In vivo SERS signals at the tumor site were lower than those of the surrounding tissue after one day of injection of the NPs, suggesting that cancer cells exhibited higher BCL2 expression in vivo after the injection of Au@GO NP‐Cy5‐BCL2‐NACs (Figure 17L,M). This evidence concerns the gene BCL2 and cancer.